Grants in Ireland

Scheduled

Funds three €12M innovation projects that scale efficient, reliable and resilient solar-PV manufacturing beyond today’s commercial technologies.

Scheduled

Funds one €5M coordination action to turn the EU CO2 transport and storage policy framework into workable rules, markets and investment pathways.

Scheduled

Funds two €6M projects to supply industrial processes with concentrated solar heat, storage and at least 50% annual solar coverage.

Scheduled

Funds two €8M Innovation Actions that scale direct air capture toward pilot demonstration with lower costs and full life-cycle evidence.

Scheduled

Funds two €18.9M projects to make lithium-ion and sodium-ion cell production cheaper, cleaner, flexible and ready for industrial scale-up.

Scheduled

Funds a €30M renewable-fuel co-fund that connects regions, supports annual calls and scales sustainable fuel value chains across Europe.

Scheduled

Funds a €43M Innovation Action that advances wave and tidal energy from breakthrough research to multiple monitored demonstrations.

Scheduled

Funds two €6.4M projects that turn soil-friendly biotechnology into scalable, safe and market-ready farm solutions.

Scheduled

Funds two €5.5M projects to demonstrate water-resilience solutions for healthier water cycles, smarter use and affordable access.

Scheduled

Funds two €8M projects that scale agroforestry across landscapes and make healthier soil a practical, profitable choice.

Scheduled

Funds one €7M research project that uses historical evidence to explain soil degradation and improve future soil-health decisions.

Scheduled

Funds two €5.5M projects that let communities map the health risks of polluted soils and shape safer local responses.

Scheduled

Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.

Scheduled

Funds climate-health exposome research linking lifelong exposures, disease burden, vulnerability and resilience.

Scheduled

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

Scheduled

Funds the next phase of Europe’s pandemic-preparedness partnership, clinical networks and One Health research ecosystem.

Scheduled

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.

Scheduled

Funds €6–8M projects that make cell-free protein synthesis practical for discovering and producing peptide- and protein-based biologicals.

Scheduled

Funds four €4–5M PCP projects that help healthcare systems and communities adapt to climate-related health risks.

Scheduled

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.

Scheduled

Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.

Scheduled

Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.

Scheduled

Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.

Scheduled

Funds small-molecule antivirals that expand preparedness and treatment options for future viral epidemics and pandemics.